180 related articles for article (PubMed ID: 17988532)
1. [Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients].
Xiang GD; Sun HL; Zhao LS; Hou J; Yue L
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2121-5. PubMed ID: 17988532
[TBL] [Abstract][Full Text] [Related]
2. Alteration of plasma concentrations of OPG before and after levothyroxine replacement therapy in hypothyroid patients.
Guang-Da X; Hui-Ling S; Zhi-Song C; Lin-Shuang Z
J Endocrinol Invest; 2005 Dec; 28(11):965-72. PubMed ID: 16483173
[TBL] [Abstract][Full Text] [Related]
3. Changes in endothelial function and its association with plasma osteoprotegerin in hypothyroidism with exercise-induced silent myocardial ischaemia.
Guang-da X; Hui-ling S; Jie H
Clin Endocrinol (Oxf); 2008 Nov; 69(5):799-803. PubMed ID: 18410551
[TBL] [Abstract][Full Text] [Related]
4. Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients.
Guang-da X; Hui-ling S; Zhi-song C; Lin-shuang Z
J Clin Endocrinol Metab; 2005 Oct; 90(10):5765-8. PubMed ID: 16046585
[TBL] [Abstract][Full Text] [Related]
5. Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients.
Xiang GD; Sun HL; Zhao LS
Diabetes Res Clin Pract; 2007 May; 76(2):199-206. PubMed ID: 17023086
[TBL] [Abstract][Full Text] [Related]
6. [Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients].
Xiang GD; Sun HL; Zhao LS; Hou J; Yue L; Xu L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1234-7. PubMed ID: 17686254
[TBL] [Abstract][Full Text] [Related]
7. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
8. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of serum osteoprotegerin in hypothyroid patients and its normalization with restoration of normal thyroid function.
Nagasaki T; Inaba M; Jono S; Hiura Y; Tahara H; Shirakawa K; Onoda N; Ishikawa T; Ishimura E; Nishizawa Y
Eur J Endocrinol; 2005 Mar; 152(3):347-53. PubMed ID: 15757850
[TBL] [Abstract][Full Text] [Related]
10. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.
Giusti M; Cecoli F; Fazzuoli L; De Franchis V; Ceresola E; Ferone D; Mussap M; Minuto F
Metabolism; 2007 May; 56(5):699-707. PubMed ID: 17445547
[TBL] [Abstract][Full Text] [Related]
11. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy.
Saravanan P; Siddique H; Simmons DJ; Greenwood R; Dayan CM
Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):261-7. PubMed ID: 17479444
[TBL] [Abstract][Full Text] [Related]
13. Decrease of arterial stiffness at common carotid artery in hypothyroid patients by normalization of thyroid function.
Nagasaki T; Inaba M; Kumeda Y; Ueda M; Hiura Y; Tahara H; Ishimura E; Onoda N; Ishikawa T; Nishizawa Y
Biomed Pharmacother; 2005; 59(1-2):8-14. PubMed ID: 15740929
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy.
Wadwekar D; Kabadi UM
Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):373-7. PubMed ID: 15239022
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
Akin F; Yaylali GF; Turgut S; Kaptanoglu B
Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
[TBL] [Abstract][Full Text] [Related]
16. Circulating leptin levels are not influenced by thyroid status in hypothyroid and euthyroid women.
Owecki M; El Ali Z; Wasko R; Nikisch E; Dziubandowska A; Sulikowska A; Sowiński J
Neuro Endocrinol Lett; 2007 Aug; 28(4):417-21. PubMed ID: 17693966
[TBL] [Abstract][Full Text] [Related]
17. Serum insulin levels and the degree of thyroid dysfunction in hypothyroid women.
Owecki M; El Ali Z; Nikisch E; Sowiński J
Neuro Endocrinol Lett; 2008 Feb; 29(1):137-40. PubMed ID: 18283245
[TBL] [Abstract][Full Text] [Related]
18. Does thyroid replacement therapy affect pulmonary function tests in patients with subclinical hypothyroidism?
Koral L; Hekimsoy Z; Yildirim C; Ozmen B; Yorgancioglu A; Girgin A
Saudi Med J; 2006 Mar; 27(3):329-32. PubMed ID: 16532092
[TBL] [Abstract][Full Text] [Related]
19. Heart rate variability and its response to thyroxine replacement therapy in patients with hypothyroidism.
Xing H; Shen Y; Chen H; Wang Y; Shen W
Chin Med J (Engl); 2001 Sep; 114(9):906-8. PubMed ID: 11780378
[TBL] [Abstract][Full Text] [Related]
20. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
